Immatics IMTX
NASDAQ IMTX
$9.56 +0.10 (+1.06%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immatics (IMTX) Change in Receivables (2019 - 2026)

Immatics (IMTX) posted Change in Receivables of -$3.4 million for Q4 2025, down 133.62% sequentially from -$1.4 million in Q3 2025, and down 8.71% YoY from -$3.7 million in Q4 2024.

Analysis

Immatics (IMTX) Change in Receivables (2019 - 2026) Analysis & Trends

Immatics has reported Change in Receivables for 7 years, with the latest figure at -$3.4 million in Q4 2025.

  • Quarterly Change in Receivables fell 8.71% year-over-year to -$3.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$433406.6 (up 76.66% YoY) and the FY2025 annual result came in at -$273414.3, up 85.68% from the prior year.
  • Change in Receivables slipped to -$3.4 million in Q4 2025 per IMTX's latest filing, from -$1.4 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $4.1 million in Q2 2025 and troughed at -$3.8 million in Q4 2023.
  • A 5-year average of -$263618.7 and a median of -$131326.2 in 2024 frame the typical range for Change in Receivables.
  • The widest YoY moves for Change in Receivables: up 1479.64% in 2023, down 13576.12% in 2023.
  • Over 5 years, Change in Receivables stood at $50334.7 in 2021, then slumped by 43.25% to $28566.9 in 2022, then slumped by 13576.12% to -$3.8 million in 2023, then climbed by 19.34% to -$3.1 million in 2024, then declined by 8.71% to -$3.4 million in 2025.
  • According to Business Quant data, Change in Receivables over the past three periods registered -$3.4 million, -$1.4 million, and $4.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 140.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 838.50 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -53.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 117.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 31.60 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 37.16 Mn
10 Immatics 1.17 Bn 711.21 Mn - -1.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.55 Mn
Mar 31, 2026 2.28 Mn
Dec 31, 2025 -3.38 Mn
Sep 30, 2025 -1.44 Mn
Jun 30, 2025 4.12 Mn
Mar 31, 2025 270,334.30
Dec 31, 2024 -3.11 Mn
Sep 30, 2024 -154,848.95
Jun 30, 2024 -1.11 Mn
Mar 31, 2024 2.51 Mn
Dec 31, 2023 -3.85 Mn
Sep 30, 2023 -201,389.24
Jun 30, 2023 -107,803.51
Mar 31, 2023 944,540.80
Dec 31, 2022 28,566.93
Sep 30, 2022 -178,464.56
Jun 30, 2022 -233,685.41
Mar 31, 2022 -68,462.60
Dec 31, 2021 50,334.72
Sep 30, 2021 -8,255.01